≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Diseases of spleen

DOID EFO Endpoint Browser PheWeb

D3_SPLEENDISEASE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D73
  • Cause of death: ICD-10 — D73

2 out of 7 registries used, show all original rules.

586

4. Check minimum number of events

None

586

5. Include endpoints

605

6. Filter based on genotype QC (FinnGen only)

605

Control definitions (FinnGen only)

Control exclude
D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D70-D77
Name in latin
Morbi lienis

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4031 1960 2041
Only index persons 3439 1713 1726
Unadjusted period prevalence (%)
Whole population 0.06 0.06 0.06
Only index persons 0.06 0.06 0.07
Median age at first event (years)
Whole population 59.75 60.79 58.66
Only index persons 58.74 59.31 58.18

-FinnGen-

Key figures

All Female Male
Number of individuals 605 307 298
Unadjusted period prevalence (%) 0.12 0.10 0.13
Median age at first event (years) 61.12 58.24 64.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
547
Matched controls
5469
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D73.5
ICD-10 Finland
Infarction of spleen
+∞
191.2
172
*
D73.1
ICD-10 Finland
Hypersplenism
+∞
140.9
129
*
D73.9
ICD-10 Finland
Disease of spleen, unspecified
+∞
81.3
76
*
XW000
NOMESCO Finland
Bone marrow biopsy
15.9
67.5
114
89
D73.4
ICD-10 Finland
Cyst of spleen
+∞
62.7
59
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
84.3
60.6
67
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.2
56.2
173
377
D73.8
ICD-10 Finland
Other diseases of spleen
+∞
51.9
49
*
D73.0
ICD-10 Finland
Hyposplenism
+∞
47.6
45
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.6
41.1
83
91
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
209.4
38.3
39
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.8
35.0
130
332
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.4
34.4
114
256
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
33.9
241
1068
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
346.9
33.3
33
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.8
32.9
121
304
WW500
NOMESCO Finland
Blood transfusion
9.2
30.8
66
80
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
29.3
307
1709
D64.9
ICD-10 Finland
Anaemia, unspecified
4.7
29.0
108
272
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
17.4
28.6
45
28
D70.89
ICD-10 Finland
Neutropenic splenomegaly
+∞
28.4
27
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
25.4
249
1295
J01MA12
ATC
levofloxacin; systemic
3.3
24.9
151
574
JN4BD
NOMESCO Finland
Extensive body CT
3.9
23.8
106
314
C03CA01
ATC
furosemide; systemic
2.7
23.6
212
1034
D73.3
ICD-10 Finland
Abscess of spleen
+∞
23.1
22
*
N28.0
ICD-10 Finland
Ischaemia and infarction of kidney
125.2
22.8
24
*
M04AA01
ATC
allopurinol; systemic
3.5
22.6
121
415
R50.9
ICD-10 Finland
Fever, unspecified
3.3
20.8
119
427
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
18.2
20.2
31
18
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
20.1
162
728
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
20.0
129
502
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
19.2
129
515
L01XX05
ATC
hydroxycarbamide; oral
16.6
19.0
30
19
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
18.4
18.4
28
16
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
54.4
18.1
21
*
A02BC02
ATC
pantoprazole; systemic
2.3
18.0
380
2729
WW200
NOMESCO Finland
Immunization
7.3
17.8
43
63
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
15.2
17.8
29
20
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
17.5
164
792
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
16.4
73
213
B01AB05
ATC
enoxaparin; parenteral
2.3
16.3
200
1104
ZX120
NOMESCO Finland
Intravenous
3.4
16.1
83
273
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.2
15.7
38
56
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
15.7
65
178
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
87.6
15.6
17
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
15.2
90
327
UJF32
NOMESCO Finland
Coloscopy
2.3
15.2
169
884
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.3
15.2
47
96
D73.2
ICD-10 Finland
Chronic congestive splenomegaly
+∞
14.6
14
*
JN4AD
NOMESCO Finland
Body CT examination
3.5
14.5
70
218
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
28.0
14.4
19
7
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
14.3
129
602
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
14.0
194
1113
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
13.8
151
777
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
13.7
175
966
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
21.8
13.4
19
9
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
11.3
13.1
24
22
N02AA05
ATC
oxycodone; systemic
2.6
12.9
101
434
D75.2
ICD-10 Finland
Essential thrombocytosis
71.5
12.6
14
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
12.6
107
481
AA1AD
NOMESCO Finland
CT of head and brain
2.2
12.5
148
782
D45
ICD-10 Finland
Polycythaemia vera
9.6
12.1
24
26
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
12.1
64
215
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.1
12.0
47
123
H02AB06
ATC
prednisolone; systemic
1.9
11.9
269
1837
I50.9
ICD-10 Finland
Heart failure, unspecified
2.6
11.9
93
400
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.4
11.7
58
185
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
11.7
88
369
ZXD05
NOMESCO Finland
Urgent procedure
2.0
11.7
190
1145
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
66.4
11.6
13
*
C03DA01
ATC
spironolactone; oral
2.7
11.4
83
340
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.1
11.3
64
225
B01AB10
ATC
tinzaparin; parenteral
3.5
11.3
54
168
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
17.5
11.3
17
10
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
11.2
50
147
K86.3
ICD-10 Finland
Pseudocyst of pancreas
20.5
11.2
16
8
WX892
NOMESCO Finland
Monitored bed care
2.9
11.0
67
247
Z2221
NOMESCO Finland
Medical doctor
2.0
10.9
170
1005
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.8
10.6
29
52
C07AB07
ATC
bisoprolol; oral
1.8
10.5
271
1911
S36.0
ICD-10 Finland
Injury of spleen
112.0
10.5
11
*
B99
ICPC
Blood/lymph/spleen disease other
33.2
10.4
13
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
7.7
10.3
23
31
ZXE00
NOMESCO Finland
One hour or less
1.8
10.1
224
1494
N02AX02
ATC
tramadol; systemic, rectal
1.8
10.0
241
1656
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.3
9.9
49
157
JAH00
NOMESCO Finland
Laparotomy
5.1
9.9
30
61
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.4
9.8
48
152
SPAT1255
SPAT
Intravenous administration of medicine
3.3
9.8
49
158
A10AE04
ATC
insulin glargine; parenteral
2.7
9.8
71
291
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.4
9.7
28
54
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
9.7
34
81
L03AA13
ATC
pegfilgrastim; parenteral
5.0
9.6
30
63
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
5.3
9.5
28
55
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
9.5
60
227
B01AA03
ATC
warfarin; systemic
2.1
9.5
126
693
R06.0
ICD-10 Finland
Dyspnoea
2.0
9.4
141
812
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
9.4
9
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
22.1
9.4
13
6
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.0
9.3
29
61
Z3231
NOMESCO Finland
Registered nurse
1.9
9.3
165
1014
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
9.2
108
564
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
9.2
103
526
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
9.1
125
698
D70.82
ICD-10 Finland
Drug-induced neutropenia
37.3
9.0
11
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
9.0
67
279
R4110
NOMESCO Finland
Physiotherapy
1.9
8.9
158
967
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
8.2
8.9
19
24
J01MA02
ATC
ciprofloxacin; systemic
1.8
8.9
221
1511
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
8.8
8.9
18
21
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.1
8.8
23
39
J01DB01
ATC
cefalexin; oral
1.9
8.8
441
3751
JAH01
NOMESCO Finland
Laparoscopy
4.3
8.7
31
75
A46
ICD-10 Finland
Erysipelas
2.2
8.7
92
459
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
10.3
8.6
16
16
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
8.5
200
1343
127
Kela drug reimbursment
Transplant complication
7.5
8.5
19
26
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
20.4
8.5
12
6
TGC00
NOMESCO Finland
Bronchial lavation
5.0
8.5
26
54
R04.0
ICD-10 Finland
Epistaxis
2.9
8.5
50
182
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
6.4
8.4
21
34
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
7.2
8.3
19
27
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
14.8
8.2
13
9
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
8.2
67
291
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.5
8.2
23
43
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
8.1
265
1955
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.0
8.1
21
36
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
22.4
8.0
11
5
R11
ICD-10 Finland
Nausea and vomiting
2.7
7.9
53
208
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
7.9
37
115
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
7.8
88
450
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
15.3
7.7
12
8
WX402
NOMESCO Finland
General anaesthesia
2.1
7.6
92
483
N18.8
ICD-10 Finland
Other chronic renal failure
4.5
7.5
25
57
A05AA02
ATC
ursodeoxycholic acid; oral
7.3
7.5
17
24
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
81.1
7.4
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
13.6
7.4
12
9
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
7.3
7
*
R53
ICD-10 Finland
Malaise and fatigue
1.9
7.3
114
664
P01AB01
ATC
metronidazole; oral, rectal
1.7
7.3
206
1447
A06AD11
ATC
lactulose; oral
2.1
7.3
84
431
1XC02
NOMESCO Finland
NA
16.0
7.3
11
7
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.1
7.2
26
65
ZX108
NOMESCO Finland
Inhalation
20.3
7.2
10
5
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
5.7
7.1
19
34
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.1
7.1
37
125
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
10.2
7.1
13
13
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
7.0
110
639
UJK02
NOMESCO Finland
ERCP
4.6
7.0
23
52
A02BC05
ATC
esomeprazole; systemic
1.7
7.0
216
1549
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
7.0
180
1224
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.7
7.0
45
174
N02BE01
ATC
paracetamol; systemic, rectal
1.8
6.9
456
4007
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.7
6.9
15
20
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.2
6.9
34
110
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
6.9
109
637
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
6.9
93
513
TK800
NOMESCO Finland
Hemodialysis
4.6
6.8
22
49
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
9.5
6.8
13
14
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
6.8
39
139
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
40.6
6.8
8
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
40.6
6.8
8
*
K76.6
ICD-10 Finland
Portal hypertension
40.6
6.8
8
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
6.8
71
353
JLC10
NOMESCO Finland
Distal pancreatectomy
16.9
6.8
10
6
I81
ICD-10 Finland
Portal vein thrombosis
16.9
6.8
10
6
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
16.9
6.8
10
6
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
22.8
6.7
9
*
JKA20
NOMESCO Finland
Cholecystectomy
4.0
6.7
25
65
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
6.7
80
420
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.4
6.6
55
243
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.9
6.6
38
136
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
6.6
72
364
3AC01
NOMESCO Finland
NA
8.8
6.6
13
15
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.8
6.6
26
71
H02AB04
ATC
methylprednisolone; systemic
2.0
6.6
81
428
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.3
6.5
31
98
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.6
6.5
27
77
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
6.5
27
77
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
70.6
6.4
7
*
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
70.6
6.4
7
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
14.5
6.4
10
7
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
14.5
6.4
10
7
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.4
121
748
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.4
6.4
29
89
K86.1
ICD-10 Finland
Other chronic pancreatitis
6.7
6.4
15
23
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
5.3
6.4
18
35
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
5.6
6.3
17
31
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
6.3
106
628
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.5
6.3
28
84
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.1
6.3
33
112
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
18.3
6.3
9
5
JM1AT
NOMESCO Finland
Cytology of spleen with ultrasound guidance
+∞
6.3
6
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
27.0
6.2
8
*
B28
ICPC
Limited function/disability (B)
27.0
6.2
8
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
27.0
6.2
8
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.1
6.2
18
36
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
3.1
6.1
31
103
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
6.1
72
374
WX002
NOMESCO Finland
Sedation and analgesia
1.8
6.1
109
662
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.1
94
543
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
6.0
39
151

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
266
511
8.51
146.89
7.4
3.8
u/l
294.6
239.9
2.92
259
484
(3045142) Bone marrow Pathology biopsy report
80
41
22.33
105.22
1.7
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
217
539
5.72
87.02
5.4
2.4
%
2.2
1.8
4.65
202
484
(3023520) Reticulocytes [#/volume] in Blood
176
397
5.84
77.79
6.0
2.5
e9/l
83.2
69.8
3.24
142
302
(3042111) Morphology [Interpretation] in Bone marrow Narrative
79
72
12.47
76.07
1.9
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
372
1579
4.52
73.17
13.3
5.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
163
374
5.60
70.13
3.9
2.4
g/l
10.4
10.8
0.52
148
346
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
73
67
12.25
69.84
2.3
3.3
u/ml
931.7
3080.2
—
6
8
(3023368) Bacteria identified in Blood by Culture
332
1336
4.29
69.35
9.3
4.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
80
90
10.09
66.40
6.9
5.5
iu/ml
238.1
286.0
0.14
14
13
(3022096) Basophils/100 leukocytes in Blood
436
2191
4.54
65.26
13.5
5.8
%
0.7
0.7
0.99
421
2045
(3006504) Eosinophils/100 leukocytes in Blood
440
2256
4.48
63.24
13.5
5.7
%
2.6
2.9
1.25
424
2106
(3019069) Monocytes/100 leukocytes in Blood
441
2269
4.48
62.97
14.1
6.0
%
9.1
8.7
1.34
426
2133
(3002030) Lymphocytes/100 leukocytes in Blood
443
2315
4.41
61.15
14.0
5.8
%
26.8
27.3
0.40
427
2163
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
210
658
4.36
60.68
4.1
2.4
%
23.2
23.0
0.08
182
563
(3000093) Morphology [Interpretation] in Blood Narrative
50
30
18.08
60.59
1.2
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
54
38
15.51
60.32
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
94
145
7.49
60.06
4.1
2.5
u/ml
0.3
0.3
0.12
72
73
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
87
123
8.09
60.02
2.9
2.7
%
200.3
184.6
0.68
82
118
(3020779) Urea [Moles/volume] in Serum or Plasma
160
415
4.88
58.82
11.5
7.5
mmol/l
11.3
9.5
1.99
155
391
(3018677) aPTT in Platelet poor plasma by Coagulation assay
226
763
4.13
58.68
3.4
1.9
s
31.7
29.7
2.23
219
741
(3004789) Transferrin [Mass/volume] in Serum or Plasma
214
697
4.20
58.38
3.9
2.4
g/l
2.2
2.3
1.29
204
646
(3028026) IgM [Mass/volume] in Serum or Plasma
132
296
5.42
57.55
2.3
1.5
g/l
1.1
1.6
1.15
117
275
(3013115) Eosinophils [#/volume] in Blood
456
2500
4.35
57.09
13.4
5.8
e9/l
0.2
0.2
0.06
414
2216
(3019198) Lymphocytes [#/volume] in Blood
453
2475
4.30
56.93
12.1
5.6
e9/l
1.9
1.9
0.43
416
2197
(3004588) Protein electrophoresis panel - Serum or Plasma
135
312
5.28
56.82
2.0
2.5
—
—
—
0
0
(3036489) Thrombin time
98
168
6.77
56.61
2.7
2.2
s
21.9
21.7
0.13
89
153
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
166
457
4.63
56.45
3.7
2.3
g/l
0.2
0.2
0.83
156
429
(3001604) Monocytes [#/volume] in Blood
445
2414
4.19
56.20
12.0
5.5
e9/l
0.7
0.6
2.87
404
2099
(3020630) Protein [Mass/volume] in Serum or Plasma
148
375
4.90
55.77
2.1
2.8
g/l
64.6
66.5
1.70
140
341
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
462
2583
4.34
55.55
15.1
6.2
umol/l
13.9
11.3
3.04
447
2443
(3006315) Basophils [#/volume] in Blood
445
2428
4.15
55.38
12.1
5.5
e9/l
0.0
0.0
1.47
404
2115
(3022948) Iron [Moles/volume] in Serum or Plasma
220
761
3.97
54.65
4.0
2.4
umol/l
12.0
13.1
1.13
210
700
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
110
219
5.92
54.52
2.5
1.8
g/l
1.3
1.5
1.28
90
193
(3018010) Neutrophils/100 leukocytes in Blood
428
2291
3.97
54.42
12.9
5.6
%
57.5
57.7
0.12
412
2149
(3003458) Phosphate [Moles/volume] in Serum or Plasma
198
652
4.03
52.51
8.9
5.6
mmol/l
1.1
1.0
1.58
186
597
(3012095) Magnesium [Moles/volume] in Serum or Plasma
216
770
3.81
50.84
5.2
3.5
mmol/l
0.8
0.8
0.35
205
725
(3024561) Albumin [Mass/volume] in Serum or Plasma
400
2117
3.63
50.19
12.0
4.7
g/l
33.7
35.7
7.85
388
1970
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
280
1205
3.46
48.83
3.2
2.1
mg/l
3.9
3.0
4.15
243
1034
(3032080) INR in Blood by Coagulation assay
384
2010
3.49
48.43
15.6
9.3
inr
1.3
1.3
0.13
108
577
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
77
121
7.15
48.07
1.9
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
52
50
11.28
47.91
1.1
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
470
2821
3.99
47.08
19.0
8.7
e9/l
4.6
4.1
1.56
438
2477
(3004809) Band form neutrophils/100 leukocytes in Blood
58
68
9.33
46.32
6.5
3.8
%
1.5
0.7
1.83
49
58
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
170
546
3.94
46.08
7.4
3.0
umol/l
9.4
8.5
0.25
155
481
(3011412) CD3 cells [#/volume] in Blood
46
40
12.36
45.20
2.5
1.5
e9/l
1.5
0.9
1.67
28
19
(3017143) Hepatitis C virus Ab [Presence] in Serum
165
536
3.86
43.79
1.7
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
80
146
6.16
43.07
2.4
3.7
ratio
1.4
2.1
—
6
16
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
81
150
6.08
42.96
2.4
3.7
mg/l
46.8
32.0
0.63
68
122
(3034860) Kappa light chains.free [Mass/volume] in Serum
81
150
6.08
42.96
2.4
3.7
mg/l
56.9
95.2
0.42
67
121
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
414
2396
3.31
41.66
13.7
6.8
mmol/l
1.2
1.2
0.54
355
2042
(40760888) Immunoglobulin light chains.free panel - Serum
68
109
6.90
41.54
2.3
4.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
70
116
6.69
41.43
5.2
2.4
umol/l
41.8
34.0
1.37
59
97
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
191
706
3.49
41.42
1.7
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
275
1265
3.15
41.39
4.5
2.7
umol/l
1817.7
6776.5
1.74
241
1094
(3033658) Prothrombin time (PT) actual/Normal
267
1214
3.15
40.91
10.7
3.9
%
81.9
90.2
5.64
261
1185
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
311
1558
3.05
39.86
5.3
2.4
u/l
56.3
56.0
0.04
292
1460
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
385
2176
3.12
39.59
11.9
5.9
mmol/l
1.2
1.2
2.08
364
1974
(46235355) HIV 1 and 2 tests - Meaningful Use set
210
844
3.28
39.50
1.8
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
123
350
4.16
39.02
7.0
4.3
%
0.8
0.4
1.46
54
87
(3042936) Bacteria identified in Isolate by Culture
190
727
3.35
38.65
3.4
2.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
53
70
8.20
38.37
1.3
1.1
u/l
88.8
21.0
0.87
41
62
(3021879) Hepatitis B virus core Ab [Presence] in Serum
119
336
4.16
38.10
1.5
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
131
397
3.94
38.00
7.7
4.3
%
1.1
0.8
0.46
72
126
(4035726)
134
416
3.85
37.52
1.7
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
173
636
3.41
37.42
1.5
1.3
titre
531.3
458.8
0.18
39
147
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
34
25
14.35
36.78
1.4
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
26
13.80
35.96
1.9
1.7
%
10.2
13.6
0.64
21
15
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
33
25
13.90
35.08
1.9
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
208
894
3.02
34.10
2.0
1.7
nmol/l
1126.6
1186.9
0.41
166
685
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
384
2284
2.86
33.85
9.9
4.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
55
88
6.78
33.53
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
296
1547
2.79
33.47
6.6
2.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
170
5.04
33.46
2.1
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
170
5.04
33.46
2.1
2.1
g/l
6.7
7.5
2.35
53
126
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
54
85
6.88
33.42
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
120
375
3.74
33.01
7.7
4.4
%
0.1
0.1
0.05
68
115
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
52
80
7.02
32.87
1.4
1.5
u/ml
107.1
106.5
0.01
12
17
(3001122) Ferritin [Mass/volume] in Serum or Plasma
359
2083
2.78
32.85
5.4
2.7
ug/l
289.2
127.0
2.40
345
1919
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
113
341
3.85
32.69
2.6
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
170
4.97
32.50
2.1
2.1
g/l
3.3
3.8
2.36
51
122
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
302
1625
2.71
31.80
7.0
3.3
u/l
40.4
32.5
1.55
296
1548
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
52
83
6.76
31.74
1.2
1.2
u/ml
320.3
296.5
0.17
31
50
(3026782) Osmolality of Urine
212
953
2.89
31.66
3.6
2.8
mosm/kgh2o
518.0
568.8
2.64
196
812
(3018095) Leukocytes [#/volume] in Urine
313
1719
2.70
31.56
5.0
3.6
e6/l
155.8
108.0
0.23
249
1233
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
227
1060
2.83
31.52
2.4
1.7
mg/l
1.6
1.2
1.19
187
814
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
78
184
4.72
31.26
2.5
1.8
ug/l
2.7
3.1
0.07
70
162
(3037756) Immunofixation for Serum or Plasma
56
98
6.20
31.25
1.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
282
1482
2.69
30.91
4.4
3.1
e6/l
48.6
93.5
0.44
235
1144
(3030467) Casts [#/volume] in Urine by Automated count
265
1351
2.71
30.86
4.3
3.0
e6/l
0.4
0.4
0.19
219
1010
(3000991) Gas panel - Venous blood
123
408
3.53
30.80
9.3
8.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
157
4.99
30.73
2.1
2.2
g/l
10.0
10.6
0.42
59
134
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
61
119
5.59
30.39
2.4
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
256
1301
2.68
29.77
4.1
3.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
519
3782
3.62
29.23
20.1
7.4
u/l
90.9
77.6
7.48
506
3548
(3000850) Epithelial cells [#/volume] in Urine
216
1018
2.74
29.06
3.3
2.5
e6/l
7.0
5.1
0.92
201
890
(3048929) Epstein Barr virus Ab [Presence] in Serum
63
132
5.21
28.98
1.3
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
157
4.83
28.83
2.2
2.2
g/l
3.3
3.1
0.30
51
123
(3025159) Blasts/100 leukocytes in Blood
109
349
3.59
28.70
7.5
4.5
%
0.2
0.1
0.41
58
97
(3018418) pH of Serum or Plasma
269
1421
2.61
28.65
7.3
3.8
ph
7.4
7.4
0.24
55
267
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
181
795
2.82
27.72
3.1
1.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
33
36
9.64
27.61
2.8
1.4
e6/l
456.1
694.2
1.19
15
16
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
57
115
5.37
27.33
2.5
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
25
18
14.44
27.22
2.8
4.5
%
80.5
97.2
1.15
25
18
(3014576) Chloride [Moles/volume] in Serum or Plasma
154
626
2.96
27.17
10.1
6.5
mmol/l
103.9
104.2
0.26
154
609
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
63
143
4.80
26.35
2.3
2.5
g/l
0.6
0.9
0.41
55
125
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
121
442
3.17
25.63
4.9
2.4
u/l
37.4
43.2
0.22
106
371
(3007164) IgA [Mass/volume] in Serum or Plasma
196
934
2.62
25.23
2.2
1.4
g/l
2.4
2.4
0.08
138
589
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
60
137
4.75
24.90
1.6
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
123
461
3.09
24.88
7.0
3.4
mmol/l
1.9
2.0
0.12
99
369
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
135
537
2.95
24.56
2.7
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
58
132
4.75
24.15
1.7
2.4
g/l
0.0
0.0
0.31
52
119
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
76
213
3.94
24.15
2.3
2.1
u/l
45.2
39.1
0.89
66
194
(3017354) Segmented neutrophils/100 leukocytes in Blood
34
46
7.77
23.98
6.0
3.1
%
62.3
55.8
0.68
24
35
(3013826) Glucose [Moles/volume] in Serum or Plasma
426
2943
2.51
23.56
10.2
4.7
mmol/l
7.1
6.7
2.09
414
2736
(3014111) Lactate [Moles/volume] in Serum or Plasma
117
439
3.06
23.54
7.5
6.9
mmol/l
1.6
1.4
0.71
112
420
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
224
1170
2.45
23.44
6.1
2.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
58
136
4.61
23.28
2.0
2.3
g/l
37.7
37.5
0.08
49
116
(40768795) Lymph node Pathology biopsy report
33
46
7.53
22.68
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
58
139
4.51
22.64
2.4
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
132
542
2.84
22.49
2.9
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
54
123
4.72
22.44
1.7
2.4
g/l
0.0
0.0
0.00
48
110
(3027801) Oxygen [Partial pressure] in Arterial blood
135
562
2.80
22.41
10.0
8.2
kpa
11.7
12.0
0.24
129
542
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
135
562
2.80
22.41
10.1
8.2
kpa
5.0
5.1
0.69
130
540
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
88
5.44
22.27
1.7
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
81
5.64
22.15
2.6
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
39
67
6.15
22.08
1.7
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
488
3648
2.75
21.96
6.9
4.0
mm/h
16.6
11.9
6.10
469
3352
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
41
76
5.71
21.48
1.4
1.3
u/ml
3.5
4.7
0.39
24
34
(3003396) Base excess in Arterial blood by calculation
133
561
2.76
21.45
10.3
8.3
mmol/l
1.0
1.1
0.13
107
444
(40758558) Short blood count panel - Blood
226
1225
2.35
21.37
14.6
6.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
20
15
13.75
21.18
1.0
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
39
70
5.89
21.12
1.7
2.0
g/l
0.5
0.9
0.90
31
57
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
122
496
2.83
21.08
2.9
4.6
ug/l
26.1
33.1
0.10
103
414
(3021589) Normoblasts [#/volume] in Blood
334
2141
2.25
20.98
21.5
9.1
e9/l
0.1
0.0
1.35
289
1762
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
252
1443
2.28
20.82
4.4
3.0
ng/l
1957.1
1365.1
0.91
238
1233
(3031040) Bacteria [#/volume] in Urine by Automated count
445
3229
2.43
20.57
6.4
4.3
e6/l
42.2
2879.8
—
5
56
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
72
5.72
20.51
1.4
1.3
u/ml
10.2
5.0
0.24
22
27
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
26
9.57
20.10
1.5
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
26
9.57
20.10
1.5
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
134
585
2.66
20.09
2.0
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
29
40
7.56
20.08
1.8
1.3
g/l
2.8
2.7
0.13
23
30
(3027135) IgG subclass 1 [Mass/volume] in Serum
29
40
7.56
20.08
1.8
1.3
g/l
7.8
7.0
0.37
22
30
(3024139) IgG subclass 3 [Mass/volume] in Serum
29
40
7.56
20.08
1.8
1.3
g/l
0.5
0.4
0.38
23
29
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
70
5.73
20.02
1.4
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
142
642
2.58
19.81
1.4
1.2
—
—
—
0
0
(4062490)
29
42
7.20
19.24
1.8
1.3
—
—
—
0
0
(4306422)
37
69
5.65
19.24
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
310
1979
2.16
19.06
2.6
2.0
pmol/l
91.1
94.8
0.71
194
1032
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
85
303
3.10
18.48
1.7
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
58
5.96
18.24
6.8
3.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
52
6.23
17.94
1.2
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
64
195
3.55
17.90
3.0
3.6
u/ml
55.4
657.6
0.83
56
167
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
301
1938
2.10
17.67
3.0
2.3
nmol/l
75.4
76.2
0.17
275
1725
(3037467) Urinalysis macro (dipstick) panel - Urine
450
3385
2.29
17.49
6.4
4.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
155
769
2.37
17.45
3.7
2.9
e6/l
4.4
2.0
1.60
84
414
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
32
57
5.87
17.44
2.4
2.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
106
440
2.71
17.40
2.4
1.8
nmol/l
362.6
377.7
0.32
98
401
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
95
373
2.84
17.34
5.3
3.8
ng/l
112.1
83.0
1.32
87
330
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
69
227
3.30
17.11
7.0
3.5
mmol/l
24.1
24.2
0.07
64
201
(44790047)
32
60
5.58
16.53
2.1
1.7
—
—
—
0
0
(44806118)
32
60
5.58
16.53
2.1
1.7
—
—
—
0
0
(44790049)
32
60
5.58
16.53
2.1
1.7
—
—
—
0
0
(44790048)
32
60
5.58
16.53
2.1
1.7
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
17
15
11.63
16.27
3.0
1.6
e6/l
30263.1
4708.4
—
10
8
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
25
37
7.00
16.25
1.8
2.2
%
42.2
46.8
0.38
11
14
(40760892) CBC W Ordered Manual Differential panel - Blood
195
1094
2.15
16.14
8.6
4.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
160
829
2.26
16.14
3.6
2.7
e6/l
1.6
1.1
0.86
90
470
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
36
77
4.91
16.08
1.8
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
29
51
5.92
16.00
1.9
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
259
1630
2.03
15.64
5.0
3.4
mmol/l
2.3
2.4
1.44
234
1425
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
241
1478
2.05
15.64
2.8
2.1
u/l
157.8
310.3
1.34
235
1391
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
38
89
4.49
15.22
2.0
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
32
65
5.14
15.15
1.8
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
127
611
2.37
15.14
30.7
23.6
inr
1.6
1.3
0.55
13
81
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
34
73
4.88
15.12
1.2
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
14
10
14.31
15.09
2.6
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
56
175
3.42
15.03
2.4
2.9
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
20
9.25
14.72
1.5
1.1
ratio
1.3
1.1
—
7
5
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
71
260
2.96
14.64
14.5
11.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
169
929
2.14
14.52
5.2
3.7
ng/l
484.3
391.3
0.19
141
719
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
37
89
4.36
14.33
6.3
3.6
%
57.4
57.4
0.01
37
89
(3019060) Gas panel - Arterial blood
80
317
2.76
14.26
9.3
5.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
57
5.29
14.24
2.8
1.8
—
—
—
0
0
(4268621)
27
50
5.61
14.12
2.1
2.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
69
254
2.94
14.09
5.3
2.3
%
1.4
1.2
0.60
69
254
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
143
3.56
13.85
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
51
5.49
13.83
2.9
1.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
15
14
10.96
13.80
3.1
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
231
1453
1.95
13.50
4.0
3.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
79
321
2.68
13.39
5.1
3.7
kpa
5.1
5.1
0.04
71
297
(3009343) pH of Capillary blood
78
315
2.69
13.38
5.1
3.7
ph
7.4
7.4
—
10
33
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
77
4.48
13.28
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
75
299
2.72
13.19
4.7
3.8
mmol/l
1.6
1.6
0.04
53
234
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
68
258
2.84
13.13
8.5
10.0
mmol/l
24.3
24.5
0.13
63
242
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
47
5.51
12.87
1.2
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
65
245
2.85
12.70
5.5
2.3
%
0.7
0.7
0.12
65
239
(3048879) Bone marrow aspiration report
18
9
20.56
12.52
1.3
2.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
28
60
4.84
12.47
4.6
1.6
pg
33.1
33.6
0.25
28
60
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
418
3244
1.93
12.38
6.7
3.1
u/l
73.6
49.1
4.49
392
3043
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
28
6.97
12.36
1.4
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
92
422
2.39
12.07
2.8
2.4
ug/l
8.5
6.4
0.46
74
377
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
17
9.02
12.04
4.2
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
10
12.22
11.77
1.0
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
190
1169
1.91
11.52
2.1
1.5
nmol/l
19.0
20.7
0.83
172
1003
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
46
152
3.19
11.29
2.0
2.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
45
147
3.23
11.25
13.5
9.5
mmol/l
2.2
1.3
0.95
40
128
(3016650) Hepatitis A virus Ab [Presence] in Serum
33
89
3.86
11.00
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
326
2394
1.78
10.94
5.1
3.6
estimate
0.0
0.0
0.00
78
444
(3000570) Elastase.pancreatic [Mass/mass] in Stool
42
134
3.29
10.91
1.5
1.4
ug/g
285.8
282.8
0.03
29
80
(3021601) Nitrite [Presence] in Urine by Test strip
326
2400
1.78
10.79
6.8
4.8
estimate
0.0
0.0
0.50
78
443
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
12
10.18
10.47
1.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
272
1919
1.76
10.27
2.5
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
66
4.24
10.25
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
154
915
1.92
10.21
3.8
3.0
mmol/l
2.5
2.4
0.95
136
804
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
18
31
5.95
10.11
3.6
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
85
3.79
10.10
1.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
50
4.74
10.08
2.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
50
4.74
10.08
2.9
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
50
4.74
10.08
2.9
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
326
2431
1.74
10.04
5.1
3.6
estimate
0.0
0.0
0.50
77
428
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
16
8.28
9.77
3.9
3.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
113
613
2.04
9.70
2.2
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
66
288
2.45
9.61
2.3
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
26
6.29
9.50
1.9
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
26
6.29
9.50
1.9
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
33
5.59
9.50
1.7
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
32
94
3.54
9.45
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
32
94
3.54
9.45
1.4
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
58
240
2.57
9.44
5.1
3.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
38
125
3.18
9.41
4.3
2.6
mmol/l
23.8
24.9
0.68
32
110
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
14
8.72
9.37
2.4
4.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
21
45
4.80
9.36
1.7
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
30
5.80
9.32
4.9
3.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
265
1904
1.70
9.04
6.1
3.6
ng/l
69.9
51.7
0.22
216
1354
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
109
601
1.99
8.90
2.1
1.8
%
1.6
1.5
0.73
93
529
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
33
103
3.33
8.89
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
31
93
3.46
8.87
4.9
3.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
120
3.13
8.73
1.7
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
15
25
6.13
8.69
1.5
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
553
4939
2.39
8.64
42.0
13.7
mg/l
27.2
23.6
2.04
518
3904
(3024928) Oxygen saturation in Venous blood
33
106
3.24
8.50
5.2
2.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
21
49
4.40
8.46
1.4
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
9
14.72
8.23
2.5
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
34
5.12
8.18
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
103
574
1.96
8.12
1.4
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
10
11
9.23
8.10
3.9
3.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
74
3.63
8.05
1.2
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
5
22.36
8.04
1.4
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
107
609
1.92
7.92
1.4
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
95
3.27
7.91
3.8
2.9
nmol/l
0.8
0.9
0.68
19
75
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
94
513
1.99
7.86
5.6
3.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
36
128
2.93
7.83
5.2
3.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
197
1349
1.68
7.79
1.6
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
21
6.30
7.74
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
21
6.30
7.74
1.2
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
21
6.30
7.74
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
44
4.43
7.73
1.1
1.0
—
—
—
0
0
(3010421) pH of Blood
36
129
2.90
7.72
5.3
3.4
ph
7.4
7.4
0.87
29
103
(3028626) Oxygen [Partial pressure] in Capillary blood
32
108
3.07
7.61
3.7
2.9
kpa
8.0
8.2
0.28
27
100
(3026389) Candida sp identified in Specimen by Organism specific culture
21
54
3.99
7.49
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
18
41
4.49
7.47
4.9
3.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
31
104
3.09
7.45
5.6
3.7
mmol/l
2.3
2.6
0.29
18
64
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
437
3679
1.68
7.35
4.7
3.9
pmol/l
14.8
14.8
0.00
410
3343
(3021901) Oxygen saturation in Capillary blood
27
84
3.32
7.33
3.1
2.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
75
388
2.07
7.25
7.3
3.4
mmol/l
1.2
1.2
0.71
70
344
(3025941) Bacteria identified in Stool by Culture
60
288
2.20
7.02
1.5
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
28
93
3.11
6.86
3.6
2.3
%
15.2
16.0
0.34
15
44
(3006184) Hemoglobin [Mass/volume] in Capillary blood
29
99
3.03
6.78
2.8
2.3
g/l
124.2
130.5
0.34
18
75
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
28
94
3.07
6.74
1.4
4.0
u/ml
843.8
484.2
0.17
23
89
(3019550) Sodium [Moles/volume] in Serum or Plasma
555
5055
2.18
6.74
44.0
16.1
mmol/l
139.0
139.7
8.88
547
4918
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
28
5.09
6.73
1.6
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
10
14
7.25
6.71
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
14
7.25
6.71
1.2
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
14
7.25
6.71
1.0
2.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
556
5071
2.19
6.67
45.0
16.2
mmol/l
4.0
4.0
0.38
548
4928
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
21
5.81
6.61
1.7
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
21
5.81
6.61
3.9
1.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
21
5.81
6.61
1.7
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
21
5.81
6.61
3.9
1.9
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
32
118
2.81
6.54
1.4
1.2
u/ml
8.9
1.9
—
7
21
(3048689) Calprotectin [Mass/mass] in Stool
99
586
1.82
6.43
3.1
2.4
ug/g
315.1
125.8
1.04
80
481
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
127
809
1.72
6.42
1.4
1.3
iu/ml
80.7
36.2
0.58
39
260
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
7
14.50
6.41
2.1
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
22
5.54
6.31
3.9
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
47
3.92
6.30
2.6
2.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
17
43
4.04
6.20
1.1
1.2
u/l
57.3
51.5
0.21
12
30
(3009542) Hematocrit [Volume Fraction] of Blood
503
4466
1.75
6.19
41.8
14.8
%
37.9
40.1
5.34
343
3178
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
120
765
1.71
6.03
1.3
1.3
u/ml
25.1
12.0
0.55
37
319
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
6
15.19
5.92
1.1
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
62
323
2.02
5.89
2.5
2.7
e9/l
3.9
4.0
0.06
45
254
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
20
5.58
5.82
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
50
3.68
5.80
1.7
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
14
32
4.45
5.79
4.2
1.4
%
8.3
11.5
2.38
14
32
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
24
5.08
5.76
2.2
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
24
5.08
5.76
2.2
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
24
81
3.04
5.75
4.9
1.4
%
52.0
60.4
0.91
24
81
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
46
3.77
5.68
1.1
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
31
122
2.62
5.63
2.3
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
35
147
2.47
5.57
1.6
1.6
iu/ml
0.0
0.1
—
8
31
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
152
1049
1.60
5.57
1.4
1.2
u/ml
1.0
1.3
0.54
34
303
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
29
4.56
5.53
3.8
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
29
4.56
5.53
3.8
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
29
4.56
5.53
3.8
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
29
4.56
5.53
3.8
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
12
25
4.88
5.51
1.1
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
247
1903
1.50
5.49
5.7
3.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
39
174
2.33
5.45
2.5
3.6
g/l
0.4
0.2
1.32
24
74
(3044009) aPTT.lupus sensitive (LA screen)
8
5
16.19
5.42
1.4
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
43
201
2.23
5.39
5.5
4.4
mmol/l
25.1
24.8
0.41
38
191
(3041096) Erythrocytes [Presence] in Urine by Automated
185
1348
1.54
5.31
4.7
3.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
25
91
2.82
5.26
5.8
2.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
20
64
3.20
5.23
1.5
1.5
g/l
32.3
31.6
0.08
20
56
(3020891) Body temperature
42
197
2.22
5.23
8.7
3.9
—
—
—
0
0
(4212803)
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
155
1091
1.57
5.18
4.9
3.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
18
55
3.34
5.06
1.4
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
9
10.13
5.04
1.2
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
29
117
2.55
5.03
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
509
4606
1.66
4.96
33.0
12.8
ml/min/173m2
78.3
80.8
1.26
441
3803
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
83
2.84
4.93
1.4
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
51
3.40
4.92
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
79
474
1.77
4.89
9.0
4.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
179
1318
1.51
4.83
6.0
3.9
estimate
0.0
0.0
0.50
67
435
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
218
2.10
4.80
3.2
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
22
79
2.85
4.76
1.7
1.4
mmol/l
62.2
61.6
0.02
16
70
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
133
2.40
4.74
1.8
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
33
4.00
4.73
7.8
3.7
—
—
—
0
0
(3044889) 12 lead EKG panel
396
3410
1.47
4.70
5.4
3.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
34
153
2.29
4.68
2.4
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
53
3.27
4.64
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
110
2.52
4.61
1.3
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
7
5
14.14
4.58
1.7
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
5
14.14
4.58
1.0
2.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
70
2.92
4.53
2.8
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
70
2.92
4.53
2.8
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
70
2.92
4.53
2.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
71
2.88
4.43
2.8
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
22
83
2.71
4.37
2.0
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
16
50
3.26
4.36
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
72
2.84
4.32
2.8
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
20
72
2.84
4.32
2.8
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
459
4098
1.50
4.31
49.4
16.9
%
14.8
13.7
20.97
453
4018
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
358
3052
1.42
4.29
3.6
2.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
144
1037
1.51
4.26
1.8
1.7
pmol/l
461.4
430.2
0.74
128
855
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40
201
2.06
4.23
2.5
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
40
201
2.06
4.23
1.8
2.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
49
265
1.92
4.22
4.2
3.6
pmol/l
4.2
4.5
1.59
43
235
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
155
2.19
4.14
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
156
2.18
4.07
1.2
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
42
3.39
4.06
1.0
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
491
4468
1.53
3.99
5.7
4.6
mu/l
2.0
2.2
0.35
465
4080
(40761536) Microorganisms panel - Urine sediment
67
408
1.72
3.95
6.2
3.6
—
—
—
0
0
(4281824)
13
38
3.47
3.92
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
33
159
2.14
3.90
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
31
147
2.17
3.81
1.2
1.4
miu/ml
126.9
228.7
—
8
75
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
108
2.37
3.81
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
44
3.23
3.79
1.1
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
8
8.83
3.78
1.6
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
8
8.83
3.78
1.4
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
8
8.83
3.78
1.4
1.1
%
93.1
102.3
—
7
8
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
8
8.83
3.78
1.1
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
69
429
1.69
3.78
1.6
1.7
—
—
—
0
0
(3013512) EKG study
187
1447
1.42
3.77
5.5
3.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
39
203
1.98
3.77
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
25
4.05
3.71
3.2
1.6
g/l
0.8
0.9
—
10
25
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
12
6.74
3.68
1.9
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
14
45
3.16
3.67
1.8
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
557
5250
1.77
3.59
25.2
10.2
u/l
31.3
26.4
1.19
545
5063
(40761511) CBC panel - Blood by Automated count
549
5155
1.70
3.58
38.7
13.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
57
2.86
3.55
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
26
3.89
3.53
1.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
6
10.08
3.50
10.8
4.3
mmol/l
5.6
7.3
—
6
6
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
6
10.08
3.50
1.0
4.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
75
2.58
3.49
1.9
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
61
375
1.70
3.49
3.7
2.5
ml/min/173m2
50.7
64.9
1.84
34
156
(40761535) Cells panel - Urine sediment
66
415
1.66
3.47
4.8
3.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
16
58
2.81
3.44
1.7
1.4
e6/l
1324.2
1861.4
0.48
11
36
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
76
2.55
3.41
4.5
3.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
7
10
7.06
3.37
1.0
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
184
1449
1.39
3.29
3.7
3.3
mg/l
1584.6
194.4
1.43
135
950
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
7
8.64
3.27
1.8
1.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
6
7
8.64
3.27
2.5
3.7
pmol/l
27.5
86.0
—
6
7
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
19
4.79
3.25
5.9
7.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
19
78
2.48
3.24
4.5
3.0
mmol/l
4.2
4.1
0.67
19
78
(3035285) Chloride [Moles/volume] in Venous blood
19
78
2.48
3.24
4.5
3.0
mmol/l
103.4
105.4
0.71
19
78
(3034426) Prothrombin time (PT)
8
15
5.39
3.20
1.0
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
61
2.67
3.15
2.5
3.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
20
4.55
3.12
1.1
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
20
4.55
3.12
3.3
2.0
umol/l
22.4
27.4
—
9
20
(3023419) Bacteria identified in Sputum by Culture
17
68
2.54
3.06
1.6
2.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
16
5.05
3.06
1.1
1.1
miu/ml
1759.0
1523.7
—
8
16
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
12
5.89
3.03
1.0
1.3
%
96.3
108.7
—
7
12
(3020682) Albumin/Creatinine [Ratio] in Urine
191
1533
1.36
2.99
4.5
4.0
mg/mmol
28.0
8.5
2.01
144
995
(3009508) Creatinine [Moles/volume] in Urine
193
1554
1.36
2.96
3.5
3.1
mmol/l
6.6
7.7
3.73
164
1303
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
64
2.54
2.89
1.1
1.0
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
9
22
4.14
2.89
1.1
1.1
u/l
97.9
91.1
—
9
17
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
9
6.72
2.87
2.7
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
9
6.72
2.87
1.3
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
24
116
2.11
2.86
2.2
1.6
e6/l
21362.2
9869.4
0.80
17
88
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
6
8.39
2.75
1.4
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
72
2.40
2.74
1.9
2.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
14
5.04
2.73
4.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
14
5.04
2.73
1.6
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
92
2.21
2.70
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
142
1784
0.73
2.66
2.8
2.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
49
2.69
2.64
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
42
253
1.71
2.63
1.5
1.3
—
—
—
0
0
(4010399)
54
348
1.61
2.62
1.4
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
100
2.14
2.61
1.3
1.3
e6/l
1.6
14.5
1.06
14
77
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
15
4.71
2.60
1.6
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
81
2.26
2.56
2.2
2.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
11
5.50
2.55
1.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
50
2.64
2.54
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
21
3.85
2.47
11.0
12.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
57
2.49
2.46
1.4
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
53
346
1.58
2.45
1.2
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
27
3.37
2.40
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
40
2.78
2.38
1.3
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
8
6.29
2.37
1.2
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
98
2.08
2.34
2.0
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
35
2.89
2.31
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
485
4532
1.35
2.31
7.3
5.8
mmol/mol
40.6
39.9
0.61
442
4239
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
41
2.71
2.29
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
41
2.71
2.29
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
41
2.71
2.29
1.1
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
27
149
1.85
2.28
6.7
3.2
mmol/l
4.0
3.9
0.55
27
138
(4198724)
8
23
3.51
2.27
2.5
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
18
3.92
2.25
1.4
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
9
29
3.13
2.23
3.6
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
165
1.80
2.23
1.6
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
9
5.59
2.21
2.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
54
2.44
2.21
1.6
1.4
e6/l
7083.8
26808.2
—
8
27
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
36
2.81
2.21
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
48
2.53
2.19
1.6
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
42
2.65
2.19
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
42
2.65
2.19
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
42
2.65
2.19
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
42
2.65
2.19
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
506
4770
1.37
2.19
5.4
4.6
mmol/l
6.1
6.0
1.59
465
4351
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
123
1.90
2.14
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
136
1090
1.32
2.09
5.9
3.9
kg/l
1.0
1.0
1.05
22
150
(3035880) pH of Pleural fluid
9
31
2.93
2.08
1.7
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
31
2.93
2.08
1.2
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
10
5.03
2.07
1.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
20
3.53
2.06
1.3
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
20
3.53
2.06
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
15
4.03
2.04
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
15
4.03
2.04
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
15
4.03
2.04
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
15
4.03
2.04
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
270
0.47
2.01
1.2
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
70
2.17
1.99
1.5
1.3
nmol/l
0.6
0.6
0.23
15
65
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
57
2.31
1.99
3.2
2.8
umol/l
12.7
5.6
—
6
40
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
11
4.57
1.94
1.2
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
11
4.57
1.94
5.4
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
16
3.78
1.94
2.2
4.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
33
2.75
1.94
2.2
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
22
3.21
1.88
1.7
1.3
—
—
—
0
0
(4027681)
8
28
2.88
1.86
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
17
3.55
1.84
1.3
1.2
ug/l
12.3
9.0
—
6
17
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
29
2.78
1.79
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
47
2.37
1.78
1.9
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
25
407
0.60
1.77
1.5
1.6
—
—
—
0
0
(44813793)
8
30
2.69
1.73
1.1
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
30
2.69
1.73
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
24
2.94
1.72
1.1
2.1
—
—
—
0
0
(3000492) Spirometry study
64
472
1.40
1.69
1.8
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
119
1.79
1.68
1.8
2.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
245
1.54
1.67
2.8
2.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
62
2.12
1.66
1.6
1.3
nmol/l
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
19
3.18
1.66
1.2
1.2
iu/ml
134.0
177.9
—
6
19
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
19
3.18
1.66
3.8
2.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
31
2.60
1.66
1.5
3.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
14
69
2.05
1.65
1.3
1.4
nmol/l
0.3
0.4
—
9
53
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
11
49
2.27
1.64
1.6
1.3
u/l
24.8
28.4
0.11
11
40
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
14
3.59
1.62
5.8
10.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
14
3.59
1.62
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
168
1.64
1.58
1.4
1.4
iu/l
39.2
22.7
1.33
22
144
(3007461) Platelets [#/volume] in Blood
564
5468
1.46
1.57
59.5
20.4
e9/l
250.6
246.1
0.38
557
5351
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
130
1.72
1.55
1.1
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
564
5470
1.46
1.55
59.1
20.4
fl
91.3
91.0
0.40
559
5394
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
8
33
2.44
1.54
2.9
2.2
u/ml
21.3
62.5
—
8
33
(3010144) Erythrocytes [#/volume] in Synovial fluid
10
44
2.29
1.54
1.9
1.3
e6/l
46028.0
391857.2
—
5
31
(3035941) MCH [Entitic mass]
564
5471
1.46
1.53
59.1
20.3
pg
30.1
30.3
1.32
559
5395
(3026361) Erythrocytes [#/volume] in Blood
564
5472
1.45
1.52
59.4
20.4
e12/l
4.3
4.5
16.67
555
5341
(3010813) Leukocytes [#/volume] in Blood
564
5473
1.45
1.51
59.5
20.5
e9/l
7.9
6.7
7.24
556
5341
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
21
2.87
1.51
3.3
3.2
u/l
229.7
213.5
—
6
21
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
65
2.02
1.49
1.5
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
28
2.52
1.45
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.6
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
39
2.33
1.43
1.3
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
40
2.27
1.40
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
42
299
1.43
1.37
1.4
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
82
1.85
1.36
2.1
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
17
2.96
1.36
2.8
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
489
4669
1.25
1.34
4.7
3.9
mmol/l
1.4
1.3
3.60
446
4293
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
136
1.64
1.34
2.2
2.4
u/l
138.0
3180.7
—
9
52
(3004451) EKG impression Narrative
6
24
2.51
1.30
1.8
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
30
202
1.51
1.30
1.5
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
130
1.64
1.28
1.7
1.6
iu/l
2.1
7.2
—
6
37
(1761482) Bacteria [#/volume] in Urine by Culture
23
146
1.60
1.28
4.9
4.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
25
2.41
1.24
2.2
1.5
nmol/l
148.7
144.1
—
6
25
(3039162) Centromere protein B Ab [Units/volume] in Serum
12
63
1.92
1.23
1.3
1.3
—
75.1
—
0
5
(3005570) Glucose [Moles/volume] in Urine
10
49
2.06
1.22
2.1
2.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
100
829
1.25
1.19
1.5
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
26
2.32
1.19
1.8
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
44
328
1.37
1.14
1.2
1.2
iu/ml
157.9
144.9
0.04
12
136
(3016244) Insulin [Units/volume] in Serum or Plasma
7
30
2.35
1.12
2.9
2.8
mu/l
26.5
18.6
—
7
30
(3035320) C reactive protein [Mass/volume] in Body fluid
7
30
2.35
1.12
1.3
2.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
30
2.35
1.12
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
29
201
1.47
1.12
2.3
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
21
2.39
1.09
2.0
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
32
2.20
1.08
4.3
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
34
245
1.41
1.08
5.3
3.6
—
—
—
0
0
(1002224) Polysomnography panel
13
217
0.59
1.08
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
82
1.72
1.06
1.2
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
47
1.93
1.02
1.4
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
512
4954
1.22
0.98
5.4
4.9
mmol/l
2.4
2.7
11.55
472
4571
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
23
2.18
0.98
1.4
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
158
1.47
0.95
2.0
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
70
1.73
0.93
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
20
134
1.51
0.93
1.8
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
86
1.64
0.91
1.9
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
24
169
1.44
0.89
2.0
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
24
169
1.44
0.89
2.0
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
43
1.87
0.87
1.6
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
43
1.87
0.87
2.3
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
43
1.87
0.87
2.3
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
24
170
1.43
0.86
2.0
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
24
170
1.43
0.86
2.0
1.7
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
8
45
1.79
0.84
1.1
1.1
—
1.8
—
0
8
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
65
1.71
0.83
1.5
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
501
4858
1.18
0.82
4.9
4.4
mmol/l
4.2
4.6
13.56
465
4508
(3044242) Glucose [Moles/volume] in Arterial blood
6
32
1.88
0.82
1.7
3.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
224
0.66
0.81
1.8
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
37
473
0.77
0.81
1.2
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
10
58
1.74
0.80
1.1
1.5
pmol/l
341.0
318.3
—
10
49
(3003740) Influenza virus B Ag [Presence] in Specimen
11
66
1.68
0.79
1.5
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
66
1.68
0.79
1.5
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
25
2.01
0.73
1.2
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
38
300
1.28
0.72
2.9
2.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
57
1.59
0.71
1.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
26
1.93
0.70
1.2
2.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
71
605
1.20
0.70
14.3
7.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
496
4826
1.15
0.67
4.9
4.3
mmol/l
1.3
1.4
17.97
453
4459
(3025130) Human papilloma virus identified in Specimen
8
49
1.64
0.62
1.6
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
174
1.33
0.61
1.0
1.1
—
—
—
0
0
(4211845)
0
23
0.00
0.58
0.0
1.9
—
—
—
0
0
(4034850)
12
169
0.70
0.52
14.3
10.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
31
1.62
0.43
1.0
1.6
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
138.9
—
0
10
(3006462) Nitrate [Presence] in Urine
0
19
0.00
0.39
0.0
2.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
68
1.33
0.37
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
37
1.35
0.37
1.6
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
52
460
1.14
0.37
1.6
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
72
1.40
0.37
1.7
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
67
605
1.12
0.35
5.0
4.3
%
32.8
31.8
0.27
48
411
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
100
1.31
0.34
3.7
3.9
mg/l
47.2
30.9
—
7
67
(4146454)
6
47
1.28
0.32
2.0
2.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
83
1.33
0.32
1.1
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
193
1.20
0.31
1.5
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
56
506
1.12
0.30
1.9
1.9
—
—
—
0
0
(4094501)
10
130
0.77
0.29
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
27
233
1.17
0.28
1.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
23.3
—
0
10
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
136
1419
0.95
0.20
3.9
4.4
%
22.2
21.6
0.14
60
676
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
99
1.22
0.19
1.8
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
133
0.82
0.19
1.7
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
253
1.11
0.17
1.8
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
172
1774
0.96
0.17
5.0
4.8
ug/l
3.4
2.5
0.49
151
1590
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
67
0.74
0.17
2.0
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
8
70
1.14
0.16
1.0
1.1
—
1.2
—
0
33
(40768793) Breast Pathology biopsy report
12
102
1.18
0.15
1.4
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
99
0.81
0.13
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
62
0.80
0.08
2.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
117
1.11
0.08
1.4
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
166
1.09
0.08
1.6
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
98
1.12
0.07
3.6
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
53
548
0.96
0.06
1.5
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
14
129
1.09
0.05
1.0
1.1
—
1.8
—
0
17
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
110
1.09
0.05
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
110
1.09
0.05
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
110
1.09
0.05
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
110
1.09
0.05
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
140
0.93
0.04
1.2
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
129
1306
0.98
0.04
1.7
1.6
mmol/l
2.0
1.4
1.81
116
1104
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
143
1.05
0.01
1.8
2.4
ug/min
98.2
80.5
—
10
86
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
67
663
1.01
0.01
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
46
466
0.99
0.00
1.5
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
145
1.04
0.00
1.5
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
15
154
0.97
0.00
1.8
1.7
nmol/l
43.7
40.3
0.16
15
148
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
111
0.99
0.00
2.2
1.9
pmol/l
149.0
231.5
1.47
11
104
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
102
1019
1.00
0.00
2.9
2.9
ug/l
0.7
0.8
0.46
66
670
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
90
1.00
0.00
1.3
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
89
1.01
0.00
1.3
1.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
15.9
—
0
6
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.6
—
0
5
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
47.5
—
0
6
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
89
1.01
0.00
1.3
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_SPLEENDISEASE and mortality.

Females

Parameter HR [95% CI] p-value
D3_SPLEENDISEASE 3.971 [3.07, 5.14] < 0.001
Birth year 0.994 [0.99, 1.0] 0.19

During the follow-up period (1.1.1998 — 31.12.2019), 415 out of 1386 females with D3_SPLEENDISEASE died.

Males

Parameter HR [95% CI] p-value
D3_SPLEENDISEASE 3.698 [2.92, 4.68] < 0.001
Birth year 0.986 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 499 out of 1462 males with D3_SPLEENDISEASE died.

Mortality risk

Mortality risk for people of age

years, who have D3_SPLEENDISEASE.

N-year risk Females Males
1 0.481% 0.759%
5 2.249% 4.089%
10 5.579% 10.28%
15 10.302% 19.424%
20 17.274% 31.076%

Relationships between endpoints

↥

Index endpoint: D3_SPLEENDISEASE – Diseases of spleen

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data